Trial Search Results

Integrated Whole-Genome Analysis of Hematologic Disorders

We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University


  • Procedure: Blood Draw
  • Procedure: Skin Biopsy


Inclusion Criteria:

   1. 18 years of age or older

   2. Patient meets the clinical and/or pathologic criteria for the hematologic disorder
   being examined.

   3. Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.

Exclusion Criteria:

   1. Less than 18 years of age

   2. Patient is not willing to provide a skin biopsy and five 10 mL tubes of peripheral

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jason D Merker